Black Diamond Therapeutics, Inc. Gains 235.87%
Tue, Jun 27, 2023 at 07:53 PM
Black Diamond Therapeutics, Inc. (BDTX:NASDAQ) rocketted at $6.18, a gain of 235.9%. On Tue, Jun 27, 2023, BDTX:NASDAQ hit a New 2-Week High of $6.18. The stock got featured on our News Catalysts scanner on Tue, Jun 27, 2023 at 07:55 AM in the 'BIOTECH' category. From Tue, Jun 13, 2023, the stock recorded 44.44% Up Days and 80.00% Green Days
About Black Diamond Therapeutics, Inc. (BDTX:NASDAQ)
Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform namely, Mutation-Allostery-Pharmacology which is targeting mutations in cancer.
Top 10 Gainers:
- Black Diamond Therapeutics, Inc. (BDTX:NASDAQ), 235.87%
- AC Immune SA (ACIU:NASDAQ), 71.72%
- Leafly Holdings Inc. (LFLY:NASDAQ), 54.81%
- Centogene N.V. (CNTG:NASDAQ), 50.82%
- Tivic Health Systems Inc. (TIVC:NASDAQ), 38.96%
- Ryvyl Inc Com (New) (RVYL:NASDAQ), 36.29%
- CalciMedica Inc Com (New) (CALC:NASDAQ), 33.13%
- VivoPower International PLC (VVPR:NASDAQ), 32.35%
- Statera Biopharma Inc. (STAB:NASDAQ), 25.46%
- Enovix Corporation (ENVX:NASDAQ), 25.23%